federal_register: 2019-25901
This data as json
| document_number | title | type | abstract | publication_date | pub_year | pub_month | html_url | pdf_url | agency_names | agency_ids | excerpts |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2019-25901 | Hospira, Inc., et al.; Withdrawal of Approval of Six Abbreviated New Drug Applications | Notice | The Food and Drug Administration (FDA or Agency) is withdrawing approval of six abbreviated new drug applications (ANDAs) from multiple applicants. The applicants notified the Agency in writing that the drug products were no longer marketed and requested that the approval of the applications be withdrawn. | 2019-11-29 | 2019 | 11 | https://www.federalregister.gov/documents/2019/11/29/2019-25901/hospira-inc-et-al-withdrawal-of-approval-of-six-abbreviated-new-drug-applications | https://www.govinfo.gov/content/pkg/FR-2019-11-29/pdf/2019-25901.pdf | Health and Human Services Department; Food and Drug Administration | 221,199 | The Food and Drug Administration (FDA or Agency) is withdrawing approval of six abbreviated new drug applications (ANDAs) from multiple applicants. The applicants notified the Agency in writing that the drug products were no longer marketed and... |